Clinical Trial Update: Randomized, Controlled Single-blind Clinical Study to Assess Vaccine Interchangeability Between RV5 and RV1 Using Seven Combined Anti-rotavirus Prevention Programs [Phase 3]

View source ↗

Summary

Phase 3 randomized, single-blind study assessing interchangeability between two rotavirus vaccines (RV5 and RV1) across seven prevention programs; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Infection
• Rotavirus Vaccine-related Disease

Drugs mentioned

• RV1 (Rotavirus vaccine serotype 1-4 (monovalent))
• RV5 (Rotavirus vaccine serotype G1P[8] (pentavalent))

Snippet

Sponsor: National Institute of Pediatrics, Mexico | Conditions: Rotavirus Vaccine | Phase 3 | Status: COMPLETED